Exploring new bioprocess considerations for cardiomyogenesis of embryonic stem cells
Ex vivo cardiomyocytes production from pluripotent stem cells is highly attractive as a future clinical therapy for cardiovascular diseases. Scaled-up 3-dimensional cell culture can be used to produce clinically relevant cell numbers but requires numerous bioprocess design considerations. In this th...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
2014
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10356/61818 |